Publications by authors named "Raphael Teipel"

Claim this Profile
T
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma.
Luciano J Costa, Nizar J Bahlis, Aurore Perrot, Ajay K Nooka, Jin Lu, Raphael Teipel

N Engl J Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Efficacy of Talquetamab vs. Real-World Physician's Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent.
Hermann Einsele, Philippe Moreau, Nizar Bahlis, Manisha Bhutani, Laure Vincent, Raphael Teipel

Adv Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST.
Maximilian Merz, Nico Gagelmann, Samih Smaili, Sarah Flossdorf, Sandra Sauer, Raphael Teipel

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential BCMA CAR T-cell therapy in refractory multiple myeloma.
Tim Richardson, Udo Holtick, Jan-Hendrik Frenking, Hishan Tharmaseelan, Hyatt Balke-Want, Raphael Teipel

Blood Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A German multicenter real-world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma.
Jan H Frenking, Christine Riedhammer, Raphael Teipel, Florian Bassermann, Britta Besemer

Hemasphere· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Communicating cancer treatment with pictogram-based timeline visualizations.
Helena Klara Jambor, Julian Ketges, Anna Lea Otto, Malte von Bonin, Karolin Trautmann-Grill, Raphael Teipel

J Am Med Inform Assoc· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there still a place for autologous salvage transplantation in relapsed/refractory multiple myeloma in the era of novel therapies?
Simone Karp, Karolin Trautmann-Grill, Paul Warncke, Dominik Zolnowski, Christoph Röllig, Raphael Teipel

Ann Hematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study).
Katja Sockel, Annika Neu, Maren Goeckenjan, Markus Ditschkowski, Inken Hilgendorf, Raphael Teipel

Blood· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of scleromyxoedema with daratumumab.
Katharina Epp, Raphael Teipel, Ulrike Reuner, Martin Bornhäuser, Claudia Günther

Br J Haematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steady-state versus chemotherapy-based hematopoietic cell mobilization after anti-CD38-based induction therapy in newly diagnosed multiple myeloma.
Raphael Teipel, Susanne Rieprecht, Karolin Trautmann-Grill, Christoph Röllig, Christina Klötzer

Transfusion· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Pathological Thoracolumbar Vertebral Fractures in Patients With Multiple Myeloma: Multidisciplinary Recommendations.
Georg Osterhoff, Michael Kreinest, Thomas Kuhnt, Claudia Pohlenz, Jacques Müller-Broich, Raphael Teipel

Global Spine J· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials.
Bruno Paiva, Irene Manrique, Meletios A Dimopoulos, Francesca Gay, Chang-Ki Min, Raphael Teipel

Blood· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Relevance of clonal hematopoiesis for cellular therapies].
Raphael Teipel, Malte von Bonin, Friedrich Stölzel, Johannes Schetelig, Christian Thiede

Inn Med (Heidelb)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-disease.
Thomas Krüger, Rebekka Wehner, Maik Herbig, Martin Kräter, Michael Kramer, Raphael Teipel

Front Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macroscopic, histologic, and clinical assessment of acute graft-versus-host disease of the upper gastrointestinal tract within 6 weeks after allogeneic hematopoietic cell transplantation.
Abed A Sarraf, Johannes Schetelig, Henning Baldauf, Friedrich Stölzel, Jan Moritz Middeke, Raphael Teipel

Exp Hematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment.
Raphael Teipel, Frank Kroschinsky, Michael Kramer, Theresa Kretschmann, Katharina Egger-Heidrich

Blood Adv· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT.
Laure Vincent, Luuk Gras, Patrice Ceballos, Jürgen Finke, Jakob Passweg, Raphael Teipel

Bone Marrow Transplant· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse.
Katja Sockel, Friedrich Stölzel, Franziska Hönl, Henning Baldauf, Christoph Röllig, Raphael Teipel

Cancer Manag Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
Sandra Heuschkel, Theresa Kretschmann, Raphael Teipel, Simone von Bonin, Stephan Richter

Cancer Chemother Pharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.
Kristina Hölig, Helmuth Schmidt, Gero Hütter, Michael Kramer, Raphael Teipel

Bone Marrow Transplant· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal hematopoiesis and its emerging effects on cellular therapies.
Malte von Bonin, Helena Klara Jambor, Raphael Teipel, Friedrich Stölzel, Christian Thiede

Leukemia· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of mutations - a registry based analysis.
Jan M Middeke, Raphael Teipel, Christoph Röllig, Sebastian Stasik, Armin Zebisch

Leuk Lymphoma· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.
Kristina Hölig, Helmuth Schmidt, Gero Hütter, Michael Kramer, Raphael Teipel

Bone Marrow Transplant· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioimmunotherapy in Combination with Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Multiple Myeloma.
Frederick Fasslrinner, Friedrich Stölzel, Michael Kramer, Raphael Teipel, Claudia Brogsitter

Biol Blood Marrow Transplant· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliable isolation of human mesenchymal stromal cells from bone marrow biopsy specimens in patients after allogeneic hematopoietic cell transplantation.
Thomas Krüger, Jan Moritz Middeke, Friedrich Stölzel, Anke Mütherig, Catrin List, Raphael Teipel

Cytotherapy· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis